Harvest One Announces Increase to Size of Previously Announced Financing Related To Acquisition of ACMPR Licensed Medical Cannabis Producer United Greeneries...

and Swiss Medical Cannabis-Based Health Products Company Satipharm AG


TORONTO, ONTARIO--(Marketwired - Jan. 27, 2017) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Harvest One Capital Inc. (NEX:WON.H) ("Harvest One" or the "Company") is pleased to announce that it has increased the size of its previously announced private placement, disclosed in the news release of the Company dated January 17, 2017 (the "News Release"), from $15,000,000 to $22,000,000 plus an over-allotment option of up to an additional $3,000,000 (the "Increased Offering"). Under the Increased Offering, the Company may issue up to 33,333,333 subscription receipts (the "Subscription Receipts") at a price of $0.75 per Subscription Receipt.

The Subscription Receipts will be sold on a private placement basis through a syndicate of agents led by Mackie Research Capital Corporation and including Canaccord Genuity Corp., Dundee Capital Partners Limited and GMP Securities L.P.

Closing of the Increased Offering is expected to occur by mid-February 2017, subject to the satisfaction of customary closing conditions, including the completion of satisfactory due diligence, signing of definitive documentation and TSX Venture Exchange approval.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the intention of the parties to complete the Increased Offering and the qualifying transaction to which it relates. These transactions are subject to a number of material risks, and there is no assurance that they will be completed on the terms or within the timeframes currently contemplated, or at all. The forward-looking information contained in this press release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities to be distributed pursuant to the Increased Offering have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

All monetary references herein refer to Canadian dollars unless otherwise specified.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release nor have either of them in any way passed upon the merits of the qualifying transaction or in any way approved or disapproved of the contents of this release.

Contact Information:

MMJ Phytotech
Kristina Howe
Investor Relations Manager
+1 (604) 614 6894
khowe@mmj.ca

Harvest One Capital Inc.
Anne B. Chopra
President, CEO, CFO and Director
+1 (604) 812-2344
achopra1@novuscom.net